OOIR: Observatory of International Research

Papers

(The median citation count of Menopause-The Journal of the North American Menopause Society is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
The effect of probiotic administration on the severity of menopausal symptoms and mental health of postmenopausal women: a triple-blind randomized controlled trial in the West of Iran	487
Reflecting on the enduring effects of childhood maltreatment	130
Validation of the Menopause Transition Scale (MTS)	54
Risk factors for delayed intrauterine device removal among menopausal women in rural China	31
Psychometric properties and validity of the Menopause Rating Scale in postmenopausal Portuguese women	27
#Menopause: the menopause ontology project	21
Urban-rural differences in epidemiology and risk factors of menopause syndrome in middle-aged Chinese women	21
A call for health equity when addressing menopausal symptoms	20
Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages	19
Dietary patterns and prevalence of multimorbidity in women in southern Brazil	18
Treating where it hurts: tailoring the genitourinary syndrome of menopause treatments	18
Health screening of middle-aged women: what factors impact longevity?	16
Risk factors for future osteoporosis in perimenopausal Japanese women	16
Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis	16
Perimenopause meets life: observations from the Women Living Better Survey	16
Low-serum anti-Müllerian hormone in middle-aged women associates with obesity markers	15
Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors	14
The prevalence of osteoporosis in postmenopausal women in urban Tianjin, China and its related factors	13
The association of vasomotor symptoms during the menopausal transition and cognition in later life	13
The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study	13
Association between vitamin D and calcium intakes, breast microcalcifications, breast tissue age-related lobular involution and breast density	13
Menopause hormone therapy and urinary symptoms: a systematic review	13
Lessons Learned in Clinical Research Recruitment of Midlife Latinas During COVID-19	13
Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study	12
Examining long-term health impacts of multiparity	12

Health care concerns in women at midlife: differences by race, ethnicity, and neighborhood socioeconomic status	12
Exercise training and vascular function in postmenopausal individuals: a systematic review and meta-analysis	11
Association of parity with body mass index and cardiometabolic risk in high-parous women	11
Risk of high depressive symptoms after the final menstrual period: the Study of Women’s Health Across the Nation (SWAN)	10
Pharmacological interactions and menopausal hormone therapy: a review	10
Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis	10
Psychometric evaluation of the German Day-to-Day Impact of Vaginal Aging questionnaire using data from two intervention studies	10
Impact of the CBT-Meno protocol on menopause-specific beliefs, dysfunctional attitudes, and coping behaviors	10
Perception of higher frequency of daily hot flashes in 50-year-old women today: a study of trends over time during 48 years in the Population Study of Women in Gothenburg, Sweden	9
Efficacy and safety of lemborexant in midlife women with insomnia disorder	9
Letters to the editor	9
Network analysis of eating disorder symptoms in women in perimenopause and early postmenopause	8
Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging	8
Nonhormone treatments for vasomotor symptoms	8
Postmenopausal giant ovarian tumor: a rare case report and literature review	8
Screening for factors at midlife associated with reduced longevity in women	8
Indian physicians' attitudes and practice regarding menopause and its management: a focus group discussion	8
Impact of vitamin D supplementation on modulating heat-shock proteins in postmenopausal women: a randomized, double-blind, placebo-controlled study	7
Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?	7
Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis	7
Prasterone in the treatment of mild to moderate urge incontinence: an observational study	7
Climacteric status is associated with sexual dysfunction at the age of 46 years: a population-based study	7
Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update	7
Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea–based retrospective cohort study	7
Menopause for justice-involved women: consequences and care in prison systems	7
Menopause: The Journal of The North American Menopause Society Volume 29, 2022	7
Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial	7
Genitourinary syndrome of menopause—I know it when I see it—or do I?	7
Hysterectomy with or without ovarian conservation: similar associations with vascular health?	7
Should vitamin D supplements be prescribed routinely for midlife women?	6
Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers	6
Prophylactic salpingectomy with delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in BRCA1/2 mutation carriers: women's point of view	6
Composite dietary antioxidant intake and osteoporosis likelihood in premenopausal and postmenopausal women: a population-based study in the United States	6
Psychometric properties of a Persian version of the Vulvovaginal Symptoms Questionnaire for measuring vulvovaginal symptoms in postmenopausal women	6
2022 Annual Meeting of The North American Menopause Society October 12 – 15, 2022, Atlanta, GA	6
Uterine arcuate artery calcification as a potential marker of cardiovascular risk—a preliminary study	6
Inflamm-aging or inflamm-opause: is inflammation the cause or consequence of vasomotor symptoms?	6
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)	6
Interactions between nutrient intake and comorbidities for quality of life in premenopausal and postmenopausal women	6
Update on estrogen therapy and prevention of bone loss	6
Trends in osteoporosis medication use in US postmenopausal women: analysis of the National Health and Nutrition Examination Survey 1999-2000 through 2017-2018	6
Moving toward health equity: the influence of race and ethnicity on choice and quality of life of menopause treatment in midlife women	5
Association of ß-glucuronidase activity with menopausal status, ethnicity, adiposity, and inflammation in women	5
Testosterone use for hypoactive sexual desire disorder in postmenopausal women	5
Association of hormone preparations with bone mineral density, osteopenia, and osteoporosis in postmenopausal women: data from National Health and Nutrition Examination Survey 1999-2018	5
The association between metabolic dysfunction–associated steatotic liver disease diagnosis and vasomotor symptoms in midlife women	5
Early menopause and cardiovascular risk factors: a cross-sectional and longitudinal study	5
Menopausal vasomotor symptoms and adiponectin among midlife women	5
Hormone therapy and midlife sexuality—is estrogen a hormone of desire?	5
Associations of reproductive hormones and stress-related factors with menopausal symptoms	5

Serum uric acid levels and the risk of diabetes mellitus in premenopausal and postmenopausal women: the Suita study	5
Effects of resistance training on C-reactive protein in menopausal and postmenopausal women: a systematic review and meta-analysis of randomized controlled trials	5
Effects of nutritional interventions on the severity of depressive and anxiety symptoms of women in the menopausal transition and menopause: a systematic review, meta-analysis, and meta-regression	4
Serum total bilirubin and new-onset hypertension in perimenopausal women: a cross-sectional study	4
Menopause: The Journal of The North American Menopause Society Volume 29, 2022	4
Hot flashes and the placebo effect: effective placebo or a research artifact?	4
Differing effects of oral conjugated equine estrogen and transdermal estradiol on vitamin D metabolism in postmenopausal women: a 4-year longitudinal study	4
Correlation between plasma sphingosine-1-phosphate and the occurrence and severity of coronary heart disease in postmenopausal women	4
Changes in cardiovascular disease risk factors during menopausal transition in Japanese women: the Circulatory Risk in Communities Study (CIRCS)	4
A review of African American women's experiences in menopause	4
The range and variation in serum estradiol concentration in perimenopausal and postmenopausal women treated with transdermal estradiol in a real-world setting: a cross-sectional study	4
Effects of mixed heavy metals on kidney function in premenopausal and postmenopausal women	4
Clinical management of hypoactive sexual desire disorder in postmenopausal women	4
Sarcopenia and menopause	4
Abstract Author Index	4
Longitudinal associations of psychosocial stressors with menopausal symptoms and well-being among women in midlife	4
Lifestyle for breast cancer risk reduction	3
Shining a light on shift work	3
Interactions between genetic variants and environmental risk factors are associated with the severity of pelvic organ prolapse	3
Relationship between handgrip strength and endogenous hormones in postmenopausal women	3
Use of exogenous hormones in those at increased risk for breast cancer: contraceptive and menopausal hormones in gene carriers and other high-risk patients	3
A survey of medical cannabis use during perimenopause and postmenopause	3
Letter to the Editor	3
Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea–based cohort study	3
Association of dietary intake of n-3 polyunsaturated fatty acids with breast cancer risk in pre- and postmenopausal Chinese women	3
Limited evidence of a threshold effect for increasing adiposity on risk of symptoms at midlife	3
Estimation of placebo effect in randomized placebo-controlled trials for moderate or severe vasomotor symptoms: a meta-analysis	3
Association of hormone therapy and changes of objective sleep quality in women of late menopausal transition with sleep disorder: a preliminary study	3
A new tool in the prediction of cardiovascular disease? Perhaps	3
Investigating the efficacy and feasibility of using a whole-of-diet approach to lower circulating levels of C-reactive protein in postmenopausal women: a mixed methods pilot study	3
Mid-40s menopause transition: not premature, but associated with sexual dysfunction	3
Resistance training for postmenopausal women: systematic review and meta-analysis	3
Physical activity and exercise for hot flashes: trigger or treatment?	3
Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers	3
The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women	3
The impact of foot massage given to postmenopausal women on anxiety, fatigue, and sleep: a randomized-controlled trial	3
Response to the letter to the editor	3
Immigration transition and gastrointestinal symptoms during menopausal transition: midlife women in the US	3
Impact of a 12-minute educational video prior to initial consultation in a Mature Women’s Health and Menopause Clinic	3
Effects of topical dehydroepiandrosterone therapy in women after pelvic organ prolapse surgery	3
Diagnosis, causes, and treatment of dyspareunia in postmenopausal women	3
Self-reported menstrual cycle length during reproductive years in relation to menopausal symptoms at midlife in Project Viva	3